Pretreatment serum SCC antigen levels in patients with cervical... | Download Scientific Diagram
Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy | Radiation Oncology | Full Text
Predictive value of preoperative serum squamous cell carcinoma antigen (SCC– Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study - European Journal of Surgical
Utility of squamous cell carcinoma antigen (SCC Ag) as a tumour marker in pulmonary malignancy
CanAg® SCC EIA | Fujirebio
Identification of serum anti‑striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers
The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer | Radiation Oncology | Full Text
List of reviewed tumour markers in lung cancer | Download Table
Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis | SpringerLink
Comparison between SCC-Ag ≥4 ng/mL arm and SCC-Ag | Download Table
Detection of Squamous Cell Carcinoma Antigen with Two Systems in the follow-up of Patients with Cervical Cancer
Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy | PLOS ONE
Comparison between SCC-Ag ≥4 ng/mL arm and SCC-Ag | Download Table
Squamous Cell Carcinoma Antigen (SCC Ag) in the Diagnosis and Prognosis of Lung Cancer - ScienceDirect
![PDF] Application of tumor markers SCC-Ag, CEA, and TPA in patients with cervical precancerous lesions. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b731b378abce1302af134a73862386e966c29748/3-Table2-1.png "PDF] Application of tumor markers SCC-Ag, CEA, and TPA in patients with cervical precancerous lesions. | Semantic Scholar")
PDF] Application of tumor markers SCC-Ag, CEA, and TPA in patients with cervical precancerous lesions. | Semantic Scholar
The role of squamous cell carcinoma antigen as a prognostic and predictive factor in carcinoma of uterine cervix
Preferentially expressed antigen in melanoma as a novel diagnostic marker differentiating thymic squamous cell carcinoma from thymoma | Scientific Reports
Marker SCC AG | Badamysie.pl
Pretreatment Serum SCC-ag, Node Status, and Survival | Download Table
Predictive value of preoperative serum squamous cell carcinoma antigen (SCC– Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study - European Journal of Surgical
The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis - ScienceDirect
Using SCC Antigen and CRP Levels as Prognostic Biomarkers in Recurrent Oral Cavity Squamous Cell Carcinoma | PLOS ONE
Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy | PLOS ONE
The kinetic profile and clinical implication of SCC-Ag in squamous cervical cancer patients undergoing radical hysterectomy using the Simoa assay: a prospective observational study | BMC Cancer | Full Text
